UBS Group’s Nu Skin NUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-4,000
Closed -$246K 8011
2017
Q3
$246K Sell
4,000
-36,000
-90% -$2.21M ﹤0.01% 4709
2017
Q2
$2.51M Buy
+40,000
New +$2.28M ﹤0.01% 2799
2016
Q4
Sell
-3,200
Closed -$207K 7948
2016
Q3
$207K Buy
+3,200
New +$180K ﹤0.01% 4527
2016
Q2
Sell
-38,700
Closed -$1.48M 7893
2016
Q1
$1.48M Buy
38,700
+37,800
+4,200% +$1.25M ﹤0.01% 2934
2015
Q4
$34K Hold
900
﹤0.01% 6210
2015
Q3
$37K Hold
900
﹤0.01% 6093
2015
Q2
$42K Sell
900
-200
-18% -$10.8K ﹤0.01% 6148
2015
Q1
$66K Sell
1,100
-258,500
-100% -$13.2M ﹤0.01% 5781
2014
Q4
$11.3M Buy
+259,600
New +$11.5M 0.01% 1408

Other funds holding NUS

UBS Group's NUS Position: Q1 2026 in Review

UBS Group reduced its Nu Skin (NUS) stake by 32% in Q1 2026, selling an estimated $1.03M and leaving 236,025 shares worth $1.72M. The position accounts for ﹤0.01% of the portfolio, ranked #5103.

UBS Group first reported a position in NUS in Q4 2014 and has held it in 46 quarters since. The position peaked at $19M in Q4 2021. 178 funds tracked by Wall St. Rank hold NUS as of Q1 2026.

  • UBS Group held 236,025 shares of Nu Skin worth $1.72M as of Q1 2026.
  • UBS Group sold 113,427 Nu Skin shares in Q1 2026, an estimated $1.03M.
  • Nu Skin made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5103 holding.
  • UBS Group first reported a position in Nu Skin in Q4 2014 and has held it in 46 quarters since.
  • UBS Group's Nu Skin position peaked at $19M in Q4 2021.
  • 178 funds tracked by Wall St. Rank held Nu Skin as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.